Axsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy 23/10/2018 Medications NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics, Read more